DE3686136D1 - Fibrinolytisches agens. - Google Patents

Fibrinolytisches agens.

Info

Publication number
DE3686136D1
DE3686136D1 DE8686810518T DE3686136T DE3686136D1 DE 3686136 D1 DE3686136 D1 DE 3686136D1 DE 8686810518 T DE8686810518 T DE 8686810518T DE 3686136 T DE3686136 T DE 3686136T DE 3686136 D1 DE3686136 D1 DE 3686136D1
Authority
DE
Germany
Prior art keywords
fibrinolytic agent
glycosylation
sites
novel
pas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686810518T
Other languages
English (en)
Other versions
DE3686136T2 (de
Inventor
Bhabatosh Chaudhuri
Bernd Meyhack
Jutta Heim
Jan Van Oostrum
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE3686136D1 publication Critical patent/DE3686136D1/de
Application granted granted Critical
Publication of DE3686136T2 publication Critical patent/DE3686136T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8686810518T 1985-11-18 1986-11-13 Fibrinolytisches agens. Expired - Lifetime DE3686136T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858528321A GB8528321D0 (en) 1985-11-18 1985-11-18 Modified fibrinolytic agents

Publications (2)

Publication Number Publication Date
DE3686136D1 true DE3686136D1 (de) 1992-08-27
DE3686136T2 DE3686136T2 (de) 1992-12-17

Family

ID=10588363

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686810518T Expired - Lifetime DE3686136T2 (de) 1985-11-18 1986-11-13 Fibrinolytisches agens.

Country Status (17)

Country Link
EP (1) EP0225286B1 (de)
JP (1) JPS62272976A (de)
KR (1) KR920007666B1 (de)
AT (1) ATE78514T1 (de)
AU (1) AU598490B2 (de)
DE (1) DE3686136T2 (de)
DK (1) DK174977B1 (de)
ES (1) ES2043607T3 (de)
FI (1) FI91160C (de)
GB (1) GB8528321D0 (de)
GR (1) GR3006041T3 (de)
IE (1) IE57866B1 (de)
IL (1) IL80659A (de)
NO (1) NO175266C (de)
NZ (1) NZ218305A (de)
PT (1) PT83752B (de)
ZA (1) ZA868689B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588149T2 (de) * 1984-10-01 1997-10-09 Genzyme Corp Rekombinante DNS-Verfahren und dadurch hergestellte Produkte
US5501853A (en) * 1985-12-23 1996-03-26 Chiron Corporation Peptide plasminogen activators
US5002887A (en) * 1986-01-31 1991-03-26 Genetics Institute, Inc. Truncated thrombolytic proteins
US5258298A (en) * 1986-01-31 1993-11-02 Genetics Institute, Inc. Deletion and glycosylation mutant of human tissue plasminogen activator
US5837518A (en) * 1986-01-31 1998-11-17 Genetics Institute, Inc. Thrombolytic proteins
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
US5589361A (en) * 1986-03-18 1996-12-31 Genentech, Inc. Human tissue-type plasminogen activator variant
US5047241A (en) * 1986-07-11 1991-09-10 American Home Products Corporation Tris-Kringle plasminogen activator with novel K2 insert
EP0276846A3 (de) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Derivate des koloniestimulierenden Faktors
JPH084501B2 (ja) * 1987-03-20 1996-01-24 エーザイ株式会社 糖鎖に関する変異ｔＰＡ
US6682733B1 (en) * 1987-06-18 2004-01-27 Roche Diagnostics, Gmbh Fibrinolytic enzymes
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
US5266474A (en) * 1987-06-24 1993-11-30 Genentech, Inc. Balanced inducible transcription system
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
WO1989000191A1 (en) * 1987-07-06 1989-01-12 Genetics Institute, Inc. Novel thrombolytic proteins
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
IL90146A (en) * 1988-05-20 1994-10-07 Genentech Inc Glycosylation derivatives of tissue plasminogen activator
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
WO1991015235A1 (en) * 1990-03-30 1991-10-17 Survival Technology, Inc. t-PA ENHANCER PROFILE
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
DE69312493T2 (de) * 1992-06-03 1998-01-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
NZ271088A (en) * 1993-08-04 1996-10-28 Ciba Geigy Ag Desulphatohirudin muteins, their production, conjugates thereof and pharmaceutical compositions
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
ES2612458T3 (es) * 2012-06-14 2017-05-17 Portola Pharmaceuticals, Inc. Procedimiento para purificación de derivados de factor Xa recombinante

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
GR79202B (de) * 1982-05-05 1984-10-22 Genentech Inc
WO1984001786A1 (en) * 1982-10-28 1984-05-10 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
IE56716B1 (en) * 1983-01-19 1991-11-20 Genentech Inc Method for producing human tpa and expression vectors therefor
DE3588149T2 (de) * 1984-10-01 1997-10-09 Genzyme Corp Rekombinante DNS-Verfahren und dadurch hergestellte Produkte
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−

Also Published As

Publication number Publication date
GR3006041T3 (de) 1993-06-21
FI91160C (fi) 1994-05-25
NO864569D0 (no) 1986-11-17
DK549186A (da) 1987-05-19
NZ218305A (en) 1990-01-29
IE863028L (en) 1987-05-18
FI91160B (fi) 1994-02-15
AU6520086A (en) 1987-05-21
ZA868689B (en) 1987-06-24
NO175266B (no) 1994-06-13
IL80659A0 (en) 1987-02-27
ATE78514T1 (de) 1992-08-15
JPS62272976A (ja) 1987-11-27
EP0225286B1 (de) 1992-07-22
EP0225286A2 (de) 1987-06-10
KR920007666B1 (ko) 1992-09-14
KR870005094A (ko) 1987-06-04
PT83752A (en) 1986-12-01
FI864654A (fi) 1987-05-19
EP0225286A3 (en) 1987-10-07
ES2043607T3 (es) 1994-01-01
PT83752B (pt) 1989-06-30
DE3686136T2 (de) 1992-12-17
DK549186D0 (da) 1986-11-17
FI864654A0 (fi) 1986-11-14
NO175266C (no) 1994-09-28
AU598490B2 (en) 1990-06-28
IE57866B1 (en) 1993-05-05
GB8528321D0 (en) 1985-12-24
DK174977B1 (da) 2004-04-05
NO864569L (no) 1987-05-19
IL80659A (en) 1991-12-15

Similar Documents

Publication Publication Date Title
ATE78514T1 (de) Fibrinolytisches agens.
GB8706249D0 (en) Plasminogen activator
DK43387D0 (da) Fibrinolytisk enzym
NO882226L (no) Fibrinolytiske proteiner.
DK165787A (da) Modificeret fibrinolytisk enzym
DK165687A (da) Modificeret fibrinolytisk enzym
FI864552A0 (fi) Human-lysozym.
DK165987A (da) Modificeret fibrinolytisk enzym
DE59003161D1 (de) STABILISIERUNG VON GLYKOSYLIERTEM t-PA.
DK359888A (da) Fibrinolytisk enzym
DK165887A (da) Modificeret fibrinolytisk enzym
DK459088D0 (da) Plasminogenaktivatorer
GR3005231T3 (de)
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
IL84061A0 (en) Urokinase compositions and kits comprising them
NO922262D0 (no) Forbedret fibrinolytisk blanding
KR880014007U (ko) 모니터의 수직편향 출력회로
KR890016806U (ko) 모니터의 수직 출력회로
KR890007952U (ko) 모니터의 16그레이 영상 출력 회로
KR890020335U (ko) 모니터의 씨알티 구동회로
FI854760A (fi) Foerfarande foer homogenisering av braenslefloedet under matningen.
BR8401730A (pt) Homogeneizador e quarteador de minerio-mhq 01
ZA872332B (en) Modified fibrinolytic enzyme
IE861389L (en) LYOPHILISED t-PA
IE870828L (en) MODIFIED t-PA

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8339 Ceased/non-payment of the annual fee